|
Volumn 15, Issue 1, 1995, Pages 3-31
|
Phenserine and ring C heteroanalogues: Drug candidates for the treatment of Alzheimer's disease
a a a b c,d |
Author keywords
[No Author keywords available]
|
Indexed keywords
1 N NORPHYSOSTIGMINE;
8 N NORPHYSOSTIGMINE;
ACETYLCHOLINESTERASE;
ALKALOID;
BUTYLCARBAMOYL 1 N NORESEROLINE;
BUTYLCARBAMOYL ESEROLINE;
CARBAMIC ACID ALKYL ESTER DERIVATIVE;
CARBAMIC ACID PHENYL ESTER DERIVATIVE;
CHOLINESTERASE;
CHOLINESTERASE INHIBITOR;
CYMSERINE;
ESERAMINE;
ESERIDINE;
HEPTASTIGMINE;
HETEROCYCLIC COMPOUND;
ISOPROPYLPHENYLCARBAMOYL ESEROLINE;
OCTYLCARBAMOYL 1 N NORESEROLINE;
OCTYLCARBAMOYL ESEROLINE;
PHENSERINE;
PHENYLCARBAMOYL 1 N NORESEROLINE;
PHYSOSTIGMINE;
PHYSOSTIGMINE DERIVATIVE;
PHYSOVENINE;
PHYSOVENINE DERIVATIVE;
PHYSOVENOL PHENYLCARBAMATE;
TACRINE;
THIAPHYSOVENOL PHENYLCARBAMATE;
TOLSERINE;
UNCLASSIFIED DRUG;
UNINDEXED DRUG;
ALZHEIMER DISEASE;
ANIMAL MODEL;
CLINICAL TRIAL;
DRUG STRUCTURE;
DRUG SYNTHESIS;
ENZYME INHIBITION;
HUMAN;
NONHUMAN;
REVIEW;
ALZHEIMER DISEASE;
ANIMAL;
CHOLINESTERASE INHIBITORS;
HUMAN;
PHYSOSTIGMINE;
RATS;
STRUCTURE-ACTIVITY RELATIONSHIP;
|
EID: 0028894072
PISSN: 01986325
EISSN: 10981128
Source Type: Journal
DOI: 10.1002/med.2610150103 Document Type: Article |
Times cited : (193)
|
References (108)
|